4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-444847
EVP, Chief Financial Officer gave up 7,177 shares (to pay taxes)
- EVP, Chief Financial Officer acquired 25,230 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Duarte Ira · EVP, Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 1 in the form | +13,535 | 298,206 | D | ||
| 2026-10-30 | Shares withheld for taxes : show line 2 in the form | −3,850 | $0.28 | $1,078 | 294,356 | D |
| 2026-10-31 | Exercise or conversion : show line 3 in the form | +11,695 | 306,051 | D | ||
| 2026-10-31 | Shares withheld for taxes : show line 4 in the form | −3,327 | $0.28 | $932 | 302,724 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −13,535 | 175,957 | D |
| 2026-10-31 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −11,695 | 105,249 | D |
Loading xslF345X06/ownership.xml…